Cardlytics Reports Termination of Material Agreement
Ticker: CDLX · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement-termination, 8-k
Related Tickers: CDLX
TL;DR
Cardlytics terminated a key deal, filing an 8-K on 4/28.
AI Summary
Cardlytics, Inc. filed an 8-K on April 28, 2025, reporting the termination of a material definitive agreement and other events. The filing date indicates the earliest event reported was April 22, 2025. The company is headquartered in Atlanta, Georgia.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's operations, revenue streams, and future strategic direction.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement introduces uncertainty regarding future business relationships and financial performance.
Key Players & Entities
- Cardlytics, Inc. (company) — Registrant
- April 22, 2025 (date) — Earliest event reported
- April 28, 2025 (date) — Filing date
- 675 Ponce de Leon Avenue NE, Suite 4100 Atlanta Georgia 30308 (address) — Principal executive offices
FAQ
What specific material definitive agreement was terminated by Cardlytics, Inc.?
The filing states the termination of a material definitive agreement but does not specify which agreement in the provided text.
What is the significance of the 'Other Events' reported in this 8-K?
The filing indicates 'Other Events' were reported, but the specific nature of these events is not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported was on April 22, 2025.
What is Cardlytics, Inc.'s principal executive office address?
Cardlytics, Inc.'s principal executive offices are located at 675 Ponce de Leon Avenue NE, Suite 4100, Atlanta, Georgia 30308.
What is the SEC file number for Cardlytics, Inc.'s 8-K filing?
The SEC file number for this 8-K filing is 001-38386.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Cardlytics, Inc. (CDLX).